Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
39%
OVERLAP
BY WEIGHT
46
# OF OVERLAPPING
HOLDINGS
IHE
56
HOLDINGS
100%
ALSO IN XPH
XPH
56
HOLDINGS
94%
ALSO IN IHE
SECTOR DRIFT (IHE minus XPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IHE |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
ROYALTY PHARMA PLC CLASS A | 4.6% | 2.4% | 2.4% |
|
MERCK & CO. INC. | 5.1% | 2.4% | 2.4% |
|
JOHNSON & JOHNSON | 25.4% | 2.4% | 2.4% |
|
VIATRIS, INC. | 4.2% | 2.4% | 2.4% |
|
BRISTOL-MYERS SQUIBB CO | 5.0% | 2.3% | 2.3% |
IHE Overweight Relative to XPH
|
JOHNSON & JOHNSON | 23.0% |
|
ELI LILLY & CO | 19.5% |
|
MERCK & CO. INC. | 2.7% |
|
BRISTOL-MYERS SQUIBB CO | 2.7% |
|
PFIZER INC | 2.4% |
|
ZOETIS INC | 2.3% |
|
ROYALTY PHARMA PLC CLASS A | 2.2% |
|
VIATRIS, INC. | 1.8% |
|
ELANCO ANIMAL HEALTH, INC. | 0.9% |
 |
JAZZ PHARMACEUTICALS PLC | 0.7% |
IHE Underweight Relative to XPH
|
DEFINIUM THERAPEUTICS INC | -2.5% |
|
PHIBRO ANIMAL HEALTH CORP-A | -2.1% |
|
EDGEWISE THERAPEUTICS, INC. | -1.9% |
|
AMYLYX PHARMACEUTICALS, INC. | -1.8% |
|
ENLIVEN THERAPEUTICS, INC. | -1.8% |
|
INNOVIVA, INC. | -1.8% |
|
ARVINAS, INC. | -1.7% |
|
PACIRA PHARMACEUTICALS INC | -1.6% |
|
LIQUIDIA TECHNOLOGIES, INC. | -1.6% |
|
SUPERNUS PHARMACEUTICALS INC | -1.4% |